<div class="content-intro"><p><span style="font-size: 14pt;"><strong>Company introduction:</strong></span></p> <p><span data-ogsc="rgb(0, 0, 0)">Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care. </span></p> <p><span data-ogsc="rgb(0, 0, 0)">The Company is headquartered in London, UK, with a U.S. office in New Jersey. We believe mental health patients deserve the possibility of a better future. Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumatic stress disorder (PTSD). COMP360 is a potentially first-in-class treatment and has Breakthrough Therapy designation from the U.S. Food and Drug Administration (FDA), as well as Innovative Licensing and Access Pathway (ILAP) designation in the UK for TRD. </span></p> <p><span data-ogsc="rgb(0, 0, 0)">We are leading the world’s largest classic psychedelic clinical program in TRD, and building upon that robust foundation, we are executing a late-stage trial evaluating COMP360 for PTSD, another condition with high unmet need. Our goal is to advance treatments that move the field of psychiatry towards treatment options that offer rapid onset and sustained durability with infrequent dosing. -<span class="Apple-converted-space"> </span><a id="OWA7b9a9bdd-820c-52e3-19e0-7302f475ddce" class="x_OWAAutoLink" href="https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fcompasspathways.com%2F&data=05%7C02%7CAlexis.Rached%40compasspathways.com%7C81c31d1d5b344b36655308deebefbd0f%7Cb94a191dccb54154868e9dcbcb3e1412%7C0%7C0%7C639207612126678649%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%7C&sdata=gtzmMKpxYEvhVQspKpFeeyQ6S%2Fq84f%2FpCwFrBs4C4Jc%3D&reserved=0" data-auth="NotApplicable" data-outlook-id="9c215bbc-5d45-4e9b-afdf-92d15cea8a68" data-ogsc=""><u>Compass Pathways</u></a></span></p></div><p><span style="font-size: 14pt;"><strong>Job overview</strong>:<strong> </strong></span></p> <p><span style="font-size: 12pt;">The Site of Care Account Lead (SOC-AL) is responsible for developing, managing, and supporting strategic relationships with priority Organized Care Groups (OCG) - Interventional Psychiatry Clinics, Health Systems, and Integrated Delivery Networks (IDN) that will serve as early adopters of COMP360 psilocybin therapy. This role focuses on account level strategy, operational readiness, and cross‑functional coordination to ensure sites of care have the infrastructure, training, and support needed to deliver high-quality psilocybin treatment. The SOC-AL partners closely with Sales, Marketing, Patient Engagement, Medical Affairs, Market Access, and Clinical Operations to build a scalable, sustainable ecosystem for COMP360 therapy. </span></p> <p><span style="font-size: 14pt;"><strong>Location:</strong></span> <span style="font-size: 12pt;">Field-based in the West region (Southern California, Oregon, Washington) and able to travel ~70% within region via plane, train, or car. </span></p> <p><span style="font-size: 14pt;"><strong>Reports to:</strong></span><strong> </strong><span style="font-size: 12pt;">Director, Site of Care Marketing. </span></p> <p><span style="font-size: 14pt;"><strong>Roles and responsibilities <br></strong>(<em>Include but are not limited to</em>): </span></p> <p><span style="font-size: 12pt;"><strong>Account Strategy & Development </strong></span></p> <ul> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Identify, prioritize, and manage relationships with high potential OCGs inclusive of Interventional Psychiatry Clinics, IDNs, health systems, and behavioral health networks</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Develop, execute, and maintain account-level business plans aimed at long term growth and joint value creation based on each OCGs operational, clinical, and strategic needs</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Guide accounts through the stages of COMP360 readiness - from initial interest to full operational capability</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Assess site capabilities, infrastructure, staffing, and training needs to support safe and effective therapy delivery</span></li> </ul> <p><span style="font-size: 12pt;"><strong>Operational Readiness & Implementation Support </strong></span></p> <ul> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Support sites in understanding and preparing for COMP360 psilocybin therapy workflows and help accounts navigate logistical requirements</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Identify operational barriers and collaborate internally to develop solutions, resources, or process improvements</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Track progress toward readiness milestones and ensure timely execution of implementation plans</span></li> <li style="font-size: 12pt;"><span style="font-size: 12pt;">Deliver or coordinate educational sessions on